JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3876
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.47M | ﹤0.01% |
8,519
-30
| -0.4% | -$4.96K |
2013 Q2
32 quarters
|
|
3877
CALL
Norwegian Cruise Line
NCLH
$6.95B
| $1.47M | ﹤0.01% |
50,000
-1,075,600
| -96% | -$32.4M |
2019 Q2
8 quarters
|
|
3878
Invesco S&P 500 Top 50 ETF
XLG
$11.8B
| $1.47M | ﹤0.01% |
45,180
-710
| -2% | -$22.3K |
2013 Q2
32 quarters
|
|
|
DFTX
3879
Definium Therapeutics
DFTX
$5.03B
| $1.47M | ﹤0.01% |
+20,885
| New | +$1.1M |
2021 Q2
0 quarters
|
|
3880
Phreesia
PHR
$625M
| $1.47M | ﹤0.01% |
23,948
-8,675
| -27% | -$452K |
2019 Q3
7 quarters
|
|
3881
CALL
Universal Health Services
UHS
$10.4B
| $1.46M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.51M |
2020 Q4
2 quarters
|
|
3882
Health Catalyst
HCAT
$132M
| $1.46M | ﹤0.01% |
26,226
-7,399
| -22% | -$394K |
2019 Q3
7 quarters
|
|
|
CFB
3883
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.45M | ﹤0.01% |
105,462
-68,604
| -39% | -$991K |
2019 Q3
7 quarters
|
|
|
ECOL
3884
DELISTED
US Ecology, Inc.
ECOL
| $1.45M | ﹤0.01% |
38,611
-29,935
| -44% | -$1.21M |
2014 Q4
26 quarters
|
|
3885
Puma Biotechnology
PBYI
$491M
| $1.45M | ﹤0.01% |
157,699
-7,439
| -5% | -$75.4K |
2013 Q2
32 quarters
|
|
3886
National CineMedia
NCMI
$198M
| $1.45M | ﹤0.01% |
28,516
-51,949
| -65% | -$2.44M |
2015 Q4
22 quarters
|
|
|
SPLK
3887
CALL
DELISTED
Splunk Inc
SPLK
| $1.45M | ﹤0.01% |
+10,000
| New | +$1.27M |
2021 Q2
0 quarters
|
|
|
SRT
3888
DELISTED
Startek Inc.
SRT
| $1.44M | ﹤0.01% |
202,477
-31,375
| -13% | -$231K |
2019 Q2
8 quarters
|
|
3889
Alkami Technology
ALKT
$1.49B
| $1.43M | ﹤0.01% |
+40,176
| New | +$1.47M |
2021 Q2
0 quarters
|
|
3890
Viper Energy
VNOM
$7.9B
| $1.43M | ﹤0.01% |
76,015
+42,532
| +127% | +$763K |
2016 Q2
20 quarters
|
|
|
KAHC.U
3891
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
| $1.42M | ﹤0.01% |
141,700
+39,700
| +39% | +$399K |
2021 Q1
1 quarter
|
|
3892
iShares Morningstar Small-Cap ETF
ISCB
$274M
| $1.42M | ﹤0.01% |
24,248
| – | – |
2020 Q4
2 quarters
|
|
3893
PUT
Illumina
ILMN
$41.2B
| $1.42M | ﹤0.01% |
3,084
| – | – |
2020 Q3
3 quarters
|
|
3894
1-800-Flowers.com
FLWS
$164M
| $1.42M | ﹤0.01% |
44,467
-66,875
| -60% | -$2.09M |
2017 Q4
14 quarters
|
|
3895
HealthStream
HSTM
$943M
| $1.42M | ﹤0.01% |
50,737
+20,324
| +67% | +$511K |
2017 Q3
15 quarters
|
|
|
HPX
3896
DELISTED
HPX Corp.
HPX
| $1.42M | ﹤0.01% |
143,773
| – | – |
2021 Q1
1 quarter
|
|
3897
CALL
Tilly's
TLYS
$140M
| $1.41M | ﹤0.01% |
88,500
| – | – |
2021 Q1
1 quarter
|
|
3898
Cognyte Software
CGNT
$645M
| $1.41M | ﹤0.01% |
57,649
-310,360
| -84% | -$7.68M |
2021 Q1
1 quarter
|
|
3899
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $1.41M | ﹤0.01% |
23,130
-357,688
| -94% | -$21.7M |
2013 Q2
32 quarters
|
|
3900
Addus HomeCare
ADUS
$2.08B
| $1.4M | ﹤0.01% |
16,085
-16,306
| -50% | -$1.59M |
2015 Q3
23 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.